EFFECT OF ONCE-WEEKLY SEMAGLUTIDE 1.0 MG ON KIDNEY OUTCOMES BY BASELINE CHARACTERISTICS: EXPLORATORY DATA FROM THE FLOW TRIAL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/efa19e3fc764942c09d6c5ab7b5e0ef3.pdf
EFFECT OF ONCE-WEEKLY SEMAGLUTIDE 1.0 MG ON KIDNEY OUTCOMES BY BASELINE CHARACTERISTICS: EXPLORATORY DATA FROM THE FLOW TRIAL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Srikanth
Bellary
Srikanth Bellary S.BELLARY@aston.ac.uk Aston University College of Health and Life Sciences Birmingham United Kingdom *
Richard E. Pratley Richard.Pratley.MD@AdventHealth.com AdventHealth Translational Research Institute Translational Research Orlando, FL United States -
Katherine R. Tuttle Katherine.Tuttle@providence.org University of Washington School of Medicine Division of Nephrology Seattle, WA United States - Providence Inland Northwest Health Providence Medical Research Center Spokane, WA United States
Peter Rossing peter.rossing@regionh.dk Steno Diabetes Center Copenhagen Complication Research Herlev Denmark - University of Copenhagen Department of Clinical Medicine Copenhagen Denmark
Kenneth W. Mahaffey kenneth.mahaffey@stanford.edu Stanford Center for Clinical Research Department of Medicine, Stanford University School of Medicine Stanford, CA United States -
Prachi Priyadarshini PCPH@novonordisk.com Novo Nordisk Global Business Services Novo Nordisk Global Business Services Bangalore India -
Christine Sofie Fuchs Jacobsen CIJB@novonordisk.com Novo Nordisk A/S Novo Nordisk A/S Søborg Denmark -
Poornima KN IPNK@novonordisk.com Novo Nordisk Global Business Services Novo Nordisk Global Business Services Bangalore India -
Johannes F.E. Mann johannes.mann@kms.mhn.de KfH Kidney Centre Department of Medicine -Nephrology München Germany - University Hospital Freidrich-Alexander University Department of Medicine - Nephrology and Hypertension Erlangen Germany
-
-
-
-
-
-